Cite
Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.
MLA
Khan, Muhammad Shahzeb, et al. “Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.” JACC. Heart Failure, vol. 10, no. 4, Apr. 2022, pp. 266–75. EBSCOhost, https://doi.org/10.1016/j.jchf.2021.12.004.
APA
Khan, M. S., Segar, M. W., Usman, M. S., Singh, S., Greene, S. J., Fonarow, G. C., Anker, S. D., Felker, G. M., Januzzi, J. L., Jr, Butler, J., & Pandey, A. (2022). Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial. JACC. Heart Failure, 10(4), 266–275. https://doi.org/10.1016/j.jchf.2021.12.004
Chicago
Khan, Muhammad Shahzeb, Matthew W Segar, Muhammad Shariq Usman, Sumitabh Singh, Stephen J Greene, Gregg C Fonarow, Stefan D Anker, et al. 2022. “Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.” JACC. Heart Failure 10 (4): 266–75. doi:10.1016/j.jchf.2021.12.004.